These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16103782)

  • 1. Unexpected improvement of sexual dysfunction during atazanavir therapy.
    Bernal E; Masiá M; Padilla S; Gutiérrez F
    AIDS; 2005 Sep; 19(13):1440-1. PubMed ID: 16103782
    [No Abstract]   [Full Text] [Related]  

  • 2. Unexpected improvement of sexual dysfunction during atazanavir therapy.
    Colebunders R; Moerman F; Nöestlinger C
    AIDS; 2006 May; 20(8):1209-10. PubMed ID: 16691078
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.
    Khanlou H; Bhatti L; Farthing C
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):124-5. PubMed ID: 16340485
    [No Abstract]   [Full Text] [Related]  

  • 4. Monotherapy with atazanavir as a simplification strategy: results from an observational study.
    Cossarini F; Salpietro S; Galli L; Gianotti N; Nozza S; Spagnuolo V; Hasson H; Bossolasco S; Lazzarin A; Tambussi G; Castagna A
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):e101-3. PubMed ID: 22728751
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal atazanavir usage in HIV-infected pregnant women and the risk of maternal and neonatal hyperbilirubinemia.
    Atrio JM; Sperling RS; Posada R; Rodriguez Caprio G; Chen KT
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e158-9. PubMed ID: 23970241
    [No Abstract]   [Full Text] [Related]  

  • 6. Atazanavir: a review of its use in the management of HIV infection.
    Swainston Harrison T; Scott LJ
    Drugs; 2005; 65(16):2309-36. PubMed ID: 16266202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.
    Murphy RL; Sanne I; Cahn P; Phanuphak P; Percival L; Kelleher T; Giordano M
    AIDS; 2003 Dec; 17(18):2603-14. PubMed ID: 14685054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atazanavir/ritonavir versus lopinavir/ritonavir: equivalent or different efficacy profiles?
    Hill A
    AIDS; 2005 Nov; 19(17):2054-5. PubMed ID: 16260922
    [No Abstract]   [Full Text] [Related]  

  • 9. Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.
    Möbius U; Lubach-Ruitman M; Castro-Frenzel B; Stoll M; Esser S; Voigt E; Christensen S; Rump JA; Fätkenheuer G; Behrens GM; Schmidt RE
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):174-80. PubMed ID: 15905733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atazanavir-related hyperbilirubinaemia is not highlighted in the British National Formulary.
    Bradbeer C; Ngwenya S; Baker P; George M
    Int J STD AIDS; 2012 Oct; 23(10):759. PubMed ID: 23104755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection].
    Rivero A; Camacho A; Pérez-Camacho I; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():45-8. PubMed ID: 20116617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.
    Cordery DV; Hesse K; Amin J; Cooper DA
    Antivir Ther; 2010; 15(7):1035-8. PubMed ID: 21041919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
    Haas DW; Zala C; Schrader S; Piliero P; Jaeger H; Nunes D; Thiry A; Schnittman S; Sension M;
    AIDS; 2003 Jun; 17(9):1339-49. PubMed ID: 12799555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative exposure to ritonavir-boosted atazanavir is associated with cholelithiasis in patients with HIV-1 infection.
    Nishijima T; Shimbo T; Komatsu H; Hamada Y; Gatanaga H; Kikuchi Y; Oka S
    J Antimicrob Chemother; 2014 May; 69(5):1385-9. PubMed ID: 24379301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Atazanavir in treatment-experienced patients.
    Sax PE
    AIDS Clin Care; 2003 Sep; 15(9):78. PubMed ID: 14666914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.
    Boffito M; Kurowski M; Kruse G; Hill A; Benzie AA; Nelson MR; Moyle GJ; Gazzard BG; Pozniak AL
    AIDS; 2004 Jun; 18(9):1291-7. PubMed ID: 15362661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
    Elion R; Berger D; Richmond G; Sension M; Dejesus E; Cimoch P; St Clair M; Yau L; Ha B;
    HIV Clin Trials; 2010; 11(3):170-3. PubMed ID: 20736153
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.
    Pavie J; Porcher R; Torti C; Medrano J; Castagna A; Valin N; Rusconi S; Ammassari A; Ghosn J; Delaugerre C; Molina JM;
    J Antimicrob Chemother; 2011 Oct; 66(10):2372-8. PubMed ID: 21821627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atazanavir and chest pain.
    Phillips M; Saxon C; Lee V
    Int J STD AIDS; 2014 May; 25(6):461-4. PubMed ID: 24108452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.